Archive: 10/11/2015

Cotellic approved for advanced melanoma

(HealthDay)—Cotellic (cobimetinib) in combination with another chemotherapy, vemurafenib (Zelboraf) has been approved by the U.S. Food and Drug Administration to treat melanoma skin cancer that has spread or cannot be surgically ...

page 2 from 11